Skip to content

EDX

EDX Medical Group Plc

Access


ISIN

GB00BNDMJS47

Bid

2.60

Mid

2.70

Ask

2.80

Key Information

Price Change
0.00%
Year High
5.38
Year Low
2.70
Last Trade
24 Mar 23
Market Cap
6.818M
Par
0.01
Bid
2.60
Mid Price
2.70
Ask
2.80
Instrument Type
Ordinary Shares
MIFID Status
MTF
Tradable Securities
252.5M
Sector
Healthcare

About EDX Medical Group Plc

EDX Medical develops and delivers innovative digital diagnostic products and services for cancer, heart disease, neurology and infectious disease testing, helping to predict disease risk, inform clinical decision-making and accelerate the development of new medicines. By translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost-effectively improve the detection of disease risk and personalise disease management in a timely fashion. Early disease detection and risk prediction is the most impactful way of reducing deaths and lowering the future costs of healthcare provision globally. EDX Medical operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development (R&D), provides testing and genomic sequencing services, undertakes quality assurance and has established expertise in the design, development, validation and sourcing of diagnostic tests at commercial scale. Key tests performed in this laboratory have been audited by the United Kingdom Accreditation Service (UKAS) and accredited to ISO 15189.

EDX Medical Group PlcAccess

Latest Trades

DateVolumePriceValue

23 Mar 23

14:38

17,0002.847,600

23 Mar 23

13:45

20,000360,000

23 Mar 23

13:45

20,000360,000

23 Mar 23

13:45

25,000375,000

10 Mar 23

13:26

400,0003.021,208,000
View all trades

Latest Announcements

DateTitle

13 Mar 23

07:00

EDX Medical Group Plc - Director Dealing

01 Mar 23

11:33

EDX Medical Group Plc - Total Voting Rights Correction

17 Feb 23

07:00

EDX Medical Group Plc - Acquisition of Torax Biosciences

20 Dec 22

07:00

EDX Medical Group Plc - Interim Report for the six-months to 30 September 2022

21 Nov 22

07:00

EDX Medical Group Plc - Collaboration Programme with Tianjin Bioscience
View all announcements

Address

Registered Address

Unit 210-211 Cambridge Science Park, Milton Road, Cambridge, CB4 0WA, United Kingdom

Email

Phone

Contacts

Corporate Adviser

Peterhouse Capital Ltd, 3rd Floor, 80 Cheapside, London, EC2V 6EE, United Kingdom

Registrar

Neville Registrars Limited , Neville House,Steelpark Road, Halesowen, West Midlands, B62 8HD, United Kingdom
Loading...

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2023. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal